Abivax (ABVX) EPS (Basic) (2022 - 2026)
Abivax (ABVX) posted quarterly EPS (Basic) of $0.0 for Q1 2026, down 41.01% year-over-year from $0.0 in Q1 2025, and up 100.0% on a QoQ basis from -$0.09 in Q4 2025.
Abivax (ABVX) EPS (Basic) (2022 - 2026) Analysis & Trends
Abivax (ABVX) has reported EPS (Basic) for 5 consecutive years, with $0.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) fell 41.01% year-over-year to $0.0; the TTM figure through Mar 2026 stood at -$0.89 (down 40.52% YoY), while the FY2025 annual figure was -$0.41, down 48.51% from the prior year.
- EPS (Basic) came in at $0.0 for Q1 2026 at Abivax, up from -$0.09 in the prior quarter.
- The five-year high for EPS (Basic) was $0.0 in Q3 2025, with the low at -$3.39 in Q4 2022.
- Average EPS (Basic) over 5 years is -$0.34, with a median of $0.0 recorded in 2024.
- The largest YoY upside for EPS (Basic) was 109.22% in 2025 against a maximum downside of 44.23% in 2025.
- Year by year, EPS (Basic) stood at -$3.39 in 2022, then soared by 94.03% to -$0.2 in 2023, then jumped by 69.32% to -$0.06 in 2024, then tumbled by 44.23% to -$0.09 in 2025, then jumped by 100.0% to $0.0 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered $0.0, -$0.09, and $0.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Genmab A | 276,399.99 Bn | 276,398.47 Bn | 831.00 Mn | 0.00 |
| 2 | Akari Therapeutics | 1,217.26 Bn | 1,217.26 Bn | - | 0.00 |
| 3 | BeOne Medicines | 419.38 Bn | 414.59 Bn | 1.35 Bn | 0.16 |
| 4 | Vertex Pharmaceuticals | 126.54 Bn | 119.30 Bn | 2.59 Bn | 4.06 |
| 5 | Pharming | 110.17 Bn | 110.12 Bn | 65.80 Mn | - |
| 6 | Regeneron Pharmaceuticals | 64.97 Bn | 56.22 Bn | 3.31 Bn | 6.99 |
| 7 | Argenx Se | 56.44 Bn | 56.44 Bn | 1.18 Bn | 0.01 |
| 8 | Alnylam Pharmaceuticals | 40.09 Bn | 37.08 Bn | 959.66 Mn | 1.55 |
| 9 | Revolution Medicines | 37.15 Bn | 37.15 Bn | - | -2.29 |
| 10 | Abivax | - | - | - | 0.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | -1.18 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | -0.67 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | -3.18 |
| Dec 31, 2022 | -3.46 |